Thai Union Ingredients is expanding its marine collagen line using tuna by-products. We review the supply chain metrics, biology, and clinical evidence gaps.
In September 2026, a new strategy detailed at Vitafoods Asia revealed how Thai Union Ingredients intends to expand its portfolio of tuna-derived materials. The company told NutraIngredients it is investigating ways to develop value-added ingredients from tuna-processing by-products. Senior Director Leena Uabumrungjit specifically named tails, gills, and blood as unused parts currently in the pipeline for possible development. This announcement provides a clear window into how the beauty supply chain is shifting toward alternative marine sources to meet growing global demand.
This news highlights a growing focus on maximizing resource efficiency within the nutritional ingredient sector. While consumers only see the finished supplements on store shelves, the supply chain starts much further back at the point of harvest. Thai Union Ingredients is described as vertically integrated, meaning it manages the entire process from the initial catch through to the finished ingredient. By controlling this pathway, ingredient suppliers aim to extract more functional value from raw materials that would otherwise be discarded entirely.
The primary biological focus of this commercial expansion centers heavily on structural proteins. Thai Union Ingredients already utilizes the skin of sustainably wild-caught tuna to produce an ingredient called ThalaCol. NutraIngredients describes ThalaCol as a high-purity, hydrolyzed Type I marine collagen peptide ingredient. In the human body, Type I collagen is a fundamental building block that provides strength and structure to skin, tendons, and connective tissues.
Hydrolyzed peptides are proteins broken down into smaller molecular weights to make them easier for the digestive system to absorb. The company actively targets this specific tuna-derived ingredient for the skin, bone, and hair-health categories. Uabumrungjit described the company’s intended life-stage positioning as a strategic effort to build, maintain, and restore structural health over time. These raw materials are explicitly aimed at younger people, mature adults, and an aging population seeking targeted cellular nutrition.
The push for new biological ingredients is driven by a manufacturing strategy known as by-product valorization. Uabumrungjit stated that 50 percent of the tuna processed by the company goes into cans, while the remaining 50 percent is considered by-products. She noted that the company currently extracts oil from tuna heads, collagen from skin, and calcium from bones. This ratio is an executive's description of their internal operations rather than a verified, industry-wide measurement of global seafood processing.
These operational metrics align directly with the company's stated goal of using every part of the tuna and achieving zero waste. The business is continually doing research and product innovation to reach these ambitious internal sustainability targets. Currently, the reported portfolio from Thai Union Ingredients includes ThalaCol tuna collagen alongside UniQ OMEGA Tuna Oil and UniQ BONE. Expanding this roster to include tails and gills represents the next phase of their long-term resource management plan.
We can already see how these specific marine ingredients transition into consumer goods in international markets. The recent report states that UniQ OMEGA Tuna Oil and UniQ BONE are utilized in supplements and functional beverages under the Thai brand ZEAVITA. Furthermore, Thai Union Ingredients reported that ThalaCol has previously been used in commercial coffee capsules. However, the published article does not specify the exact dosage, sales figures, or production volume for these consumer applications.
It is vital to separate an ingredient supplier's intended market positioning from documented clinical proof. The fact that ThalaCol is targeted at skin and hair categories merely describes its intended commercial applications for brands formulating new products. The recent event report offers no actual clinical-trial results demonstrating that this specific ingredient improves skin, hair, or bone health in consumers. Furthermore, while the tuna is described as sustainably wild-caught, the article provides no independent certification details to verify that environmental claim.
The broader scientific consensus on ingestible peptides also faces significant, ongoing scrutiny from independent researchers. A 2026 paper published in the Journal of Cosmetic Dermatology challenges the reliability of two earlier meta-analyses regarding collagen for visible skin changes. The authors of this recent paper argue that serious methodological and data-reporting problems weaken the conclusions of those previous studies. They report no actual benefit in their own dose-adjusted meta-regression, emphasizing the need for robust scientific skepticism when evaluating supplement claims.
This contested evidence highlights why consumers must look closely at the data before purchasing new formulations. Sourcing marine peptides from tuna skin does not automatically guarantee physiological results once ingested by the human body. The 2026 analysis does not establish whether a specific tuna-derived peptide is effective or ineffective, but it proves that pooled evidence is often flawed. Consumers should rely on an evidence-based framework for evaluating skincare ingredients rather than trusting broad, unsubstantiated category claims.
For consumers focused on long-term wellness, this announcement is principally about ingredient development rather than a green light to buy new supplements. It does not establish that a finished beverage or beauty product containing ThalaCol produces a specific physiological benefit. When you evaluate products, your first question should be whether the brand specifies its exact peptide source and daily dose. You can apply this exact scrutiny when reading a guide to ingredients, evidence, and safety for any oral supplement category.
You must also demand absolute clarity on the specific human clinical trials supporting the final product on the shelf. Many consumer brands cite general studies on marine peptides rather than testing their own proprietary blends in controlled human trials. If a company claims environmental superiority, look for independent documentation supporting its sustainability and traceability practices before making a purchase. Asking these practical questions helps you filter out marketing noise when selecting collagen or nutrition products for your daily routine.
Formulating for visible changes requires precision, transparency, and a commitment to rigorous testing standards. A high-quality brand will happily provide the exact molecular weight, the source material, and the clinical outcomes for its specific formula. Without this information, you are simply purchasing an idea rather than an effective, evidence-backed intervention. Prioritizing products that offer full transparency ensures that your investment supports actual, measurable outcomes over time.
The drive to turn marine processing by-products into functional materials reflects a significant, necessary shift in global ingredient manufacturing. Companies will likely continue investigating unused fish parts to meet the rising demand for ingestible beauty formulas worldwide. Yet, the gap between extracting a new protein and proving its biological efficacy in humans remains incredibly wide. As suppliers develop new peptide sources, will consumer brands step up to fund the rigorous clinical trials needed to prove they actually work?
Stay connected for research and practical guidance on skin, hair, collagen, nutrition and beauty longevity. Clear ideas for people who want to understand how appearance changes with age and make better-informed choices over time.
Understand your skin, hair and body better without chasing every new trend, treatment or promise.
explore the Blog
